Immunotoxin Methods and Protocols

More potent and selective for killing cancer cells than chemotherapy, immunotoxins constitute a new class of human therapeutics that have widespread applications and a potential that has not yet been fully recognized. In Immunotoxin Methods and Protocols, leading experts from laboratories around the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Weitere Verfasser: Hall, Walter A. (HerausgeberIn)
Format: Elektronisch E-Book
Sprache:English
Veröffentlicht: Totowa, NJ Humana Press 2001
Schriftenreihe:Methods in Molecular Biology™ 166
Schlagworte:
Online-Zugang:DE-355
DE-91
URL des Erstveröffentlichers
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000nam a2200000zcb4500
001 BV044952264
003 DE-604
005 20180906
007 cr|uuu---uuuuu
008 180517s2001 xx o|||| 00||| eng d
020 |a 9781592591145  |9 978-1-59259-114-5 
024 7 |a 10.1385/1592591140  |2 doi 
035 |a (ZDB-2-PRO)978-1-59259-114-5 
035 |a (OCoLC)730584175 
035 |a (DE-599)BVBBV044952264 
040 |a DE-604  |b ger  |e rda 
041 0 |a eng 
049 |a DE-355  |a DE-91 
050 0 |a QR185.8.A58 
082 0 |a 615/.373  |2 21 
082 0 |a 616.079  |2 23 
084 |a WC 4150  |0 (DE-625)148092:  |2 rvk 
245 1 0 |a Immunotoxin Methods and Protocols  |c edited by Walter A. Hall 
264 1 |a Totowa, NJ  |b Humana Press  |c 2001 
300 |a 1 Online-Ressource (XI, 297 p) 
336 |b txt  |2 rdacontent 
337 |b c  |2 rdamedia 
338 |b cr  |2 rdacarrier 
490 0 |a Methods in Molecular Biology™  |v 166 
520 |a More potent and selective for killing cancer cells than chemotherapy, immunotoxins constitute a new class of human therapeutics that have widespread applications and a potential that has not yet been fully recognized. In Immunotoxin Methods and Protocols, leading experts from laboratories around the world describe in step-by-step detail their cutting-edge methods for developing and applying these powerful proteins. The conjugates created by these researchers contain entire monoclonal antibodies, single chain antibody fragments, and cytokines as their carrier ligands. Their toxic portion can include such conventional chemotherapeutics as doxirubicin, such ribosome-inactivating proteins as the ricin A chain or saporin, or such bacterial toxins as diptheria toxin. Also described are a variety of applications that demonstrate the versatility of these agents, including the treatment of primary malignant brain tumors, the generation of selective brain lesions to localize critical functions, and the targeting of the AIDS virus. Each readily reproducible method is optimized for experimental success with hands-on instructions, invaluable notes on pitfalls to avoid, and informative explanations of why certain steps are necessary. Authoritative and highly practical, Immunotoxin Methods and Protocols provides today's cancer researchers, neuroscientists, and oncologists with state-of-the-art tools for exploring these powerful biological agents and their rapidly increasing applications 
650 4 |a Biomedicine 
650 4 |a Immunology 
650 4 |a Medicine 
650 4 |a Immunology 
650 0 7 |a Pharmakologie  |0 (DE-588)4045687-0  |2 gnd  |9 rswk-swf 
650 0 7 |a Immunotoxin  |0 (DE-588)4209677-7  |2 gnd  |9 rswk-swf 
655 7 |8 1\p  |0 (DE-588)4143413-4  |a Aufsatzsammlung  |2 gnd-content 
689 0 0 |a Immunotoxin  |0 (DE-588)4209677-7  |D s 
689 0 |5 DE-604 
689 1 0 |a Immunotoxin  |0 (DE-588)4209677-7  |D s 
689 1 1 |a Pharmakologie  |0 (DE-588)4045687-0  |D s 
689 1 |5 DE-604 
700 1 |a Hall, Walter A.  |4 edt 
776 0 8 |i Erscheint auch als  |n Druck-Ausgabe  |z 9780896037755 
856 4 0 |u https://doi.org/10.1385/1592591140  |x Verlag  |z URL des Erstveröffentlichers  |3 Volltext 
912 |a ZDB-2-PRO 
883 1 |8 1\p  |a cgwrk  |d 20201028  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
943 1 |a oai:aleph.bib-bvb.de:BVB01-030345018 
966 e |u https://doi.org/10.1385/1592591140  |l DE-355  |p ZDB-2-PRO  |x Verlag  |3 Volltext 
966 e |u https://doi.org/10.1385/1592591140  |l DE-91  |p ZDB-2-PRO  |x Verlag  |3 Volltext 

Datensatz im Suchindex

DE-BY-TUM_katkey 2643289
DE-BY-UBR_katkey 6025392
_version_ 1822726603203936257
any_adam_object
author2 Hall, Walter A.
author2_role edt
author2_variant w a h wa wah
author_facet Hall, Walter A.
building Verbundindex
bvnumber BV044952264
callnumber-first Q - Science
callnumber-label QR185
callnumber-raw QR185.8.A58
callnumber-search QR185.8.A58
callnumber-sort QR 3185.8 A58
callnumber-subject QR - Microbiology
classification_rvk WC 4150
collection ZDB-2-PRO
ctrlnum (ZDB-2-PRO)978-1-59259-114-5
(OCoLC)730584175
(DE-599)BVBBV044952264
dewey-full 615/.373
616.079
dewey-hundreds 600 - Technology (Applied sciences)
dewey-ones 615 - Pharmacology and therapeutics
616 - Diseases
dewey-raw 615/.373
616.079
dewey-search 615/.373
616.079
dewey-sort 3615 3373
dewey-tens 610 - Medicine and health
discipline Biologie
Medizin
doi_str_mv 10.1385/1592591140
format Electronic
eBook
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03467nam a2200565zcb4500</leader><controlfield tag="001">BV044952264</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20180906 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">180517s2001 xx o|||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781592591145</subfield><subfield code="9">978-1-59259-114-5</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1385/1592591140</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-PRO)978-1-59259-114-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)730584175</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044952264</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-91</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QR185.8.A58</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.373</subfield><subfield code="2">21</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.079</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WC 4150</subfield><subfield code="0">(DE-625)148092:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Immunotoxin Methods and Protocols</subfield><subfield code="c">edited by Walter A. Hall</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Totowa, NJ</subfield><subfield code="b">Humana Press</subfield><subfield code="c">2001</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XI, 297 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Methods in Molecular Biology™</subfield><subfield code="v">166</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">More potent and selective for killing cancer cells than chemotherapy, immunotoxins constitute a new class of human therapeutics that have widespread applications and a potential that has not yet been fully recognized. In Immunotoxin Methods and Protocols, leading experts from laboratories around the world describe in step-by-step detail their cutting-edge methods for developing and applying these powerful proteins. The conjugates created by these researchers contain entire monoclonal antibodies, single chain antibody fragments, and cytokines as their carrier ligands. Their toxic portion can include such conventional chemotherapeutics as doxirubicin, such ribosome-inactivating proteins as the ricin A chain or saporin, or such bacterial toxins as diptheria toxin. Also described are a variety of applications that demonstrate the versatility of these agents, including the treatment of primary malignant brain tumors, the generation of selective brain lesions to localize critical functions, and the targeting of the AIDS virus. Each readily reproducible method is optimized for experimental success with hands-on instructions, invaluable notes on pitfalls to avoid, and informative explanations of why certain steps are necessary. Authoritative and highly practical, Immunotoxin Methods and Protocols provides today's cancer researchers, neuroscientists, and oncologists with state-of-the-art tools for exploring these powerful biological agents and their rapidly increasing applications</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biomedicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Immunotoxin</subfield><subfield code="0">(DE-588)4209677-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Immunotoxin</subfield><subfield code="0">(DE-588)4209677-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Immunotoxin</subfield><subfield code="0">(DE-588)4209677-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hall, Walter A.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780896037755</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1385/1592591140</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-PRO</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030345018</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1385/1592591140</subfield><subfield code="l">DE-355</subfield><subfield code="p">ZDB-2-PRO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1385/1592591140</subfield><subfield code="l">DE-91</subfield><subfield code="p">ZDB-2-PRO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection>
genre 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content
genre_facet Aufsatzsammlung
id DE-604.BV044952264
illustrated Not Illustrated
indexdate 2024-12-24T06:25:55Z
institution BVB
isbn 9781592591145
language English
oai_aleph_id oai:aleph.bib-bvb.de:BVB01-030345018
oclc_num 730584175
open_access_boolean
owner DE-355
DE-BY-UBR
DE-91
DE-BY-TUM
owner_facet DE-355
DE-BY-UBR
DE-91
DE-BY-TUM
physical 1 Online-Ressource (XI, 297 p)
psigel ZDB-2-PRO
publishDate 2001
publishDateSearch 2001
publishDateSort 2001
publisher Humana Press
record_format marc
series2 Methods in Molecular Biology™
spellingShingle Immunotoxin Methods and Protocols
Biomedicine
Immunology
Medicine
Pharmakologie (DE-588)4045687-0 gnd
Immunotoxin (DE-588)4209677-7 gnd
subject_GND (DE-588)4045687-0
(DE-588)4209677-7
(DE-588)4143413-4
title Immunotoxin Methods and Protocols
title_auth Immunotoxin Methods and Protocols
title_exact_search Immunotoxin Methods and Protocols
title_full Immunotoxin Methods and Protocols edited by Walter A. Hall
title_fullStr Immunotoxin Methods and Protocols edited by Walter A. Hall
title_full_unstemmed Immunotoxin Methods and Protocols edited by Walter A. Hall
title_short Immunotoxin Methods and Protocols
title_sort immunotoxin methods and protocols
topic Biomedicine
Immunology
Medicine
Pharmakologie (DE-588)4045687-0 gnd
Immunotoxin (DE-588)4209677-7 gnd
topic_facet Biomedicine
Immunology
Medicine
Pharmakologie
Immunotoxin
Aufsatzsammlung
url https://doi.org/10.1385/1592591140
work_keys_str_mv AT hallwaltera immunotoxinmethodsandprotocols